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Threshold for Mortality
Beneﬁt at High Levels of
Cardiorespiratory FitnessAlthough the importance of achieving a “healthy”
level of cardiorespiratory ﬁtness is well established
(1), some experts have suggested that individuals
achieving extreme levels of ﬁtness are at an increased
risk of death resulting from cardiovascular disease
(CVD) (2). However, it may not be accurate to
conclude that all such individuals achieving elite
levels of ﬁtness are at increased risk (3). To inform
this debate, we sought to determine whether there
is a threshold where higher levels of ﬁtness were
no longer associated with a lower risk for all-cause
mortality.
Of 69,855 patients, we studied a subgroup of 37,855
patients free of known CVD, with high ﬁtness levels
of $10 metabolic equivalents (METs) from the Henry
Ford Exercise Testing Project (The FIT Project) (4).
Exercise capacity, expressed in METs, was estimated
from the peak treadmill workload. All patients were
followed for all-cause mortality by using linkage with
the death master ﬁle.
Follow-up was 11.5  4.5 years for all-cause mor-
tality. First, we calculated crude mortality stratiﬁed
by age and high-ﬁtness groups (METs 10 to 11, 12 to 13,
and $14). Kaplan-Meier curves were constructed
using time-to-death data, with log rank testing for
signiﬁcant differences. We then performed hierar-
chical multivariable Cox regression analysis to cal-
culate hazard ratios and 95% conﬁdence intervals
(CI) associated with increasing levels of high cardio-
respiratory ﬁtness: unadjusted; adjusted for age,
sex, and race (Model 1); and further adjustment for
traditional risk factors including smoking, diabetes,
hypertension, antihypertensive medication, hyper-
lipidemia, and family history (Model 2). Finally, using
standard post-estimation techniques from fully
adjusted regression models, we plotted estimated
mortality relative to the complete range of common
METs values (1 to 16) and constructed a graphic
assessment for a threshold effect.The mean age was 49.6  11 years of age, with
63.7% males. The mean cardiorespiratory ﬁtness level
for the high-ﬁtness population was 11.2  1.6 METs,
with 62% of patients in the 10- to 11-METs group; 33%
in the 12- to 13-METs group; and 5% in the group
at $14 METs.
Figure 1A shows a graded decrease in mortality
across increasing high cardiorespiratory ﬁtness
groups after the age of 30 years. Kaplan-Meier anal-
ysis demonstrated a statistically signiﬁcant progres-
sive improvement in survival across increasingly
high-ﬁtness groups (p < 0.001) that persisted for up
to 20 years of follow-up.
In multivariate models, there was a signiﬁcant
reduction in mortality for the most highly ﬁt groups,
independent of all study covariates. Compared with
individuals in the reference, 10- to 11-METs group,
those in the 12- to 13- and >14-METs groups had a
mortality reduction of 51% (95% CI: 0.44 to 0.54) and
79% (95% CI: 0.15 to 0.28), respectively, in an unad-
justed model; 36% (95% CI: 0.57 to 0.71) and 65%
(95% CI: 0.25 to 0.47) in Model 1; and 32% (95% CI:
0.61 to 0.75) and 61% (95% CI: 0.28 to 0.53) in Model 2,
respectively. In a graphic analysis of predicted mor-
tality across the range of commonly attained MET
values, we observed a consistent decrease in mortal-
ity with higher ﬁtness with no evidence of a threshold
effect (Figure 1B).
In summary, in a large study of cardiorespiratory
ﬁtness testing, we observed no upper threshold for
mortality beneﬁt with increasing ﬁtness, even in the
most highly ﬁt subjects. Our data appear to contrast
with recent reports in the mainstream media sig-
naling possible cardiovascular harm at the highest
exercise levels (2,3) and support the public health
message that all patients should engage in regular,
moderate to vigorous exercise (3).
In 2013, O’Keefe et al. (3) argued that mortality
reductions persist until 13 METs, at which point there
may be no additional gains and possible harms in
cardiovascular health and longevity. In fact, some
experts have advanced the concept of “cardiotox-
icity” due to the acute abnormalities associated with
extreme endurance exercise (EEE) (2). However, there
is also recognition that the changes associated with
EEE may resolve in most people and may ultimately
represent no major harm. For example, in 2012,
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630Kim et al. (5) reported that the risk of sudden cardiac
death in all U.S. marathoners from 2000 to 2010 was
0.0005%, suggesting that cardiotoxicity concerns
may be overstated.
There are several limitations to our study. The FIT
Project describes a measurement of cardiorespiratory
ﬁtness in everyday clinical practice with few extreme
athletes and cannot be considered a study of car-
diotoxicity attributable to EEE. Also, patients in The
FIT Project might have been more likely to have other
traditional cardiovascular risk factors than ultra-
marathoners, which may have accentuated the ben-
eﬁts of increasing physical ﬁtness. Finally, although
the population was large, our study still lacked suf-
ﬁcient power to model patients with >16 METs,
although exploratory analysis suggested a continued
mortality decrease in this group.spiratory Fitness and Mortality in the FIT Project
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sments reveal no upper threshold of survival among even the most
. FIT ¼ Henry Ford Exercise Testing Project; METS ¼ metabolicIn conclusion, our study suggests a continuous,
graded reduction in mortality extending to in-
dividuals with an estimated exercise capacity of >14
METs. Although more research is needed on the car-
diovascular effects of EEE, our data caution against
any public health message that might dissuade pa-
tients from routine vigorous physical activity with the
goal of reaching the highest levels of cardiorespira-
tory ﬁtness.David I. Feldman, BS
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Associate With Coronary
Plaque Vulnerability In VivoThe high local concentration of cholesterol in foam
cells has been reported to formulate cholesterol
crystals, which trigger a local inﬂammatory response
(1). Intracellular crystals also induce apoptosis of
foam cells, leading to further attraction of macro-
phages and development of a lipid-rich necrotic core
(2). These effects may suggest a potential contribu-
tion of cholesterol crystals to plaque destabilization.
Frequency-domain optical coherence tomography
